Renhuang Pharmaceuticals (CBP) Stock Research, Analysis & News

Quick Analysis on Renhuang Pharmaceuticals (CBP) Stock as of April 24, 2018

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Renhuang Pharmaceuticals (CBP) Stock below)

Renhuang Pharmaceuticals (CBP) Stock Profile Summary

China Botanic Pharmaceutical Inc. engages in the development, manufacturing, and distribution of pharmaceutical products in the Peoples Republic of China. The company offers botanical anti-depression and nerve-regulation products comprising Acanthopanax, a siberian ginseng used for regulating the nervous system, treating neurasthenia and insomnia; threat cerebrovascular and cardiovascular disease; anti-fatigue, antioxidant, and strengthening the body; and Tianma pills and compound Yangjiao tablets, which are botanic drugs used to treat headaches and regulate nerves. Its biopharmaceutical products comprise Shark vital capsule, a marine biology medicine containing squalene used for improving kidney and liver function, reducing cholesterol levels, the alleviate occurrence of heart disease, increasing leukocyte in blood, relieving fatigue, and strengthen the overall immune system. The companys botanical antibiotics and traditional over the counter Chinese medicines, such as Banlangen granules and compound Honeysuckle granules for the prevention and treatment of common cold and flu; and Shengmai granules for regulating blood flow, strengthening heart beat, and improving the immune system and blood quality. It distributes its pharmaceutical products through a network of approximately 3,000 distributors and approximately 70 sales centers. The company was formerly known as Renhuang Pharmaceuticals, Inc. and changed its name to China Botanic Pharmaceutical Inc. on November 22, 2010. The company is based in Harbin, China.

Renhuang Pharmaceuticals (CBP) Stock Key Statistics Research and Analysis as of April 24, 2018

Latest Market News on Renhuang Pharmaceuticals (CBP)

Click here to find the latest news on Renhuang Pharmaceuticals (CBP)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center